An exploratory survey regarding the Maryland Contraceptive Equity Act: clinician awareness and impact on contraception provision

Aneesha Cheedalla; Jessica K. Lee; Anne E. Burke

doi:10.1016/j.conx.2021.100071

An exploratory survey regarding the Maryland Contraceptive Equity Act: clinician awareness and impact on contraception provision

Aneesha Cheedalla, Jessica K. Lee, Anne E. Burke

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: The Maryland Contraceptive Equity Act took effect in January 2018 with the goal of reducing insurance barriers to contraception. We sought to assess the Act's impact on contraceptive provision. Study Design: From March-August 2019, we emailed an exploratory survey to clinicians providing contraception in Maryland that queried awareness of the Act and changing practices. Results: The survey had a 13% response rate (164/1256 clinicians). Fifty (31%) were aware of the Act. Clinicians rated the Act was somewhat likely to change prescribing practices (3.5/5 point Likert Scale, SD 1.3). Conclusion: The majority of clinicians providing contraception in Maryland are not aware of the Act. If aware of the Act, clinicians may change their contraceptive prescribing practices.

Original language	English (US)
Article number	100071
Journal	Contraception: X
Volume	4
DOIs	https://doi.org/10.1016/j.conx.2021.100071
State	Published - Jan 2022

Keywords

Access
Awareness
Contraception
Equity
Health policy
Legislation

ASJC Scopus subject areas

Obstetrics and Gynecology
Reproductive Medicine

Access to Document

10.1016/j.conx.2021.100071

Cite this

@article{6a62d4e6c3c8476c866551f68c389081,

title = "An exploratory survey regarding the Maryland Contraceptive Equity Act: clinician awareness and impact on contraception provision",

abstract = "Objective: The Maryland Contraceptive Equity Act took effect in January 2018 with the goal of reducing insurance barriers to contraception. We sought to assess the Act's impact on contraceptive provision. Study Design: From March-August 2019, we emailed an exploratory survey to clinicians providing contraception in Maryland that queried awareness of the Act and changing practices. Results: The survey had a 13% response rate (164/1256 clinicians). Fifty (31%) were aware of the Act. Clinicians rated the Act was somewhat likely to change prescribing practices (3.5/5 point Likert Scale, SD 1.3). Conclusion: The majority of clinicians providing contraception in Maryland are not aware of the Act. If aware of the Act, clinicians may change their contraceptive prescribing practices.",

keywords = "Access, Awareness, Contraception, Equity, Health policy, Legislation",

author = "Aneesha Cheedalla and Lee, {Jessica K.} and Burke, {Anne E.}",

note = "Funding Information: Anne Burke reports completed research support from Bayer, pending research support from Scope Intl, and ongoing support from NICHD, all mediated through Johns Hopkins University. Publisher Copyright: {\textcopyright} 2022",

year = "2022",

month = jan,

doi = "10.1016/j.conx.2021.100071",

language = "English (US)",

volume = "4",

journal = "Contraception: X",

issn = "2590-1516",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - An exploratory survey regarding the Maryland Contraceptive Equity Act

T2 - clinician awareness and impact on contraception provision

AU - Cheedalla, Aneesha

AU - Lee, Jessica K.

AU - Burke, Anne E.

N1 - Funding Information: Anne Burke reports completed research support from Bayer, pending research support from Scope Intl, and ongoing support from NICHD, all mediated through Johns Hopkins University. Publisher Copyright: © 2022

PY - 2022/1

Y1 - 2022/1

N2 - Objective: The Maryland Contraceptive Equity Act took effect in January 2018 with the goal of reducing insurance barriers to contraception. We sought to assess the Act's impact on contraceptive provision. Study Design: From March-August 2019, we emailed an exploratory survey to clinicians providing contraception in Maryland that queried awareness of the Act and changing practices. Results: The survey had a 13% response rate (164/1256 clinicians). Fifty (31%) were aware of the Act. Clinicians rated the Act was somewhat likely to change prescribing practices (3.5/5 point Likert Scale, SD 1.3). Conclusion: The majority of clinicians providing contraception in Maryland are not aware of the Act. If aware of the Act, clinicians may change their contraceptive prescribing practices.

AB - Objective: The Maryland Contraceptive Equity Act took effect in January 2018 with the goal of reducing insurance barriers to contraception. We sought to assess the Act's impact on contraceptive provision. Study Design: From March-August 2019, we emailed an exploratory survey to clinicians providing contraception in Maryland that queried awareness of the Act and changing practices. Results: The survey had a 13% response rate (164/1256 clinicians). Fifty (31%) were aware of the Act. Clinicians rated the Act was somewhat likely to change prescribing practices (3.5/5 point Likert Scale, SD 1.3). Conclusion: The majority of clinicians providing contraception in Maryland are not aware of the Act. If aware of the Act, clinicians may change their contraceptive prescribing practices.

KW - Access

KW - Awareness

KW - Contraception

KW - Equity

KW - Health policy

KW - Legislation

UR - http://www.scopus.com/inward/record.url?scp=85123274731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123274731&partnerID=8YFLogxK

U2 - 10.1016/j.conx.2021.100071

DO - 10.1016/j.conx.2021.100071

M3 - Article

C2 - 35112076

AN - SCOPUS:85123274731

SN - 2590-1516

VL - 4

JO - Contraception: X

JF - Contraception: X

M1 - 100071

ER -

An exploratory survey regarding the Maryland Contraceptive Equity Act: clinician awareness and impact on contraception provision

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this